Akzo Nobel pharmaceutical business unit deploys Portal-in-a-Box to make research more efficient
CAMBRIDGE, England, 11 June, 2001 - Autonomy Corporation plc (Nasdaq: AUTN; LSE: AU.; Nasdaq Europe: AUTN), a leading provider of infrastructure software for the Web and the enterprise, today announced that Organon, Akzo Nobel's pharmaceutical business unit, has chosen Autonomy's Portal-in-a-Box technology to power its global project Time to Market.
Time to Market is a global project designed to automate the delivery of the right information to the right people at the right time, put people with similar expertise in touch with one another and reduce product development cycles, therefore increasing efficiency.
Organon is the largest Dutch research-based pharmaceutical company and the largest pharmaceutical business unit of Akzo Nobel. The number of employees has grown to nearly 10,000 and the company is active in more than 100 countries with its own affiliates in 55.
Using Portal-in-a-Box, Organon will be able to automatically aggregate, categorise, hypertext-link, personalise and deliver business-critical information concerning all aspects of drug development and related issues, including healthcare, legislation, and marketing. No manual intervention will be necessary in this process.
Richard Gaunt, co-founder and Chief Technology Officer at Autonomy, commented: "Autonomy makes sense of information that is often vital, but simply too profuse to exploit manually. Organon produces highly specialised products for which highly relevant and timely information is necessary. Given the objectives for Time to Market, Autonomy was the natural choice. We are very pleased to welcome Organon to an international list of blue-chip pharmaceutical clients, which includes AstraZeneca and Novartis."
Rene van den Berselaar, Head of Special Projects at Organon's Infocenter, commented: "The nature of our business means that we have to deal with enormous volumes of unstructured information. The information is vital to us, but managing it manually is just not an option any more. Using Autonomy's infrastructure technology, we can automate the processes that have to be carried out on unstructured information, thus reducing our costs and, ultimately, accelerating our time to market. There is a powerful commercial advantage to be had from Autonomy, particularly as it can be deployed so rapidly."
At the heart of Autonomy's software is its ability to analyse text and voice and identify and rank the main concepts within it. It can then automatically categorise, link, personalise and deliver that information. The technology is used to automate these operations within enterprise information portals, customer relationship management, knowledge management and e-business applications.
About Autonomy
Autonomy Corporation plc (Nasdaq: AUTN; Nasdaq Europe: AUTN; LSE: AU.) is a global leader in infrastructure software for the Web and the enterprise. Autonomy's technology powers applications dependent upon unstructured information including: e-commerce, customer relationship management, knowledge management, enterprise information portals, enterprise resource planning and online publishing. Autonomy's customer base includes more than 450 global companies, including Astra Zeneca, British Aerospace, Clorox, Deutsche Bank, Ericsson, General Motors, Lucent, Royal Sun Alliance, Sun Microsystems and public sector agencies including the United States Department of Defense, NASA and the United States Department of Energy. Strategic reseller and OEM partners include leading companies such as Business Objects, Hewlett Packard, IBM Global Services, Oracle, Vignette and Sybase. The company has offices in North America, Europe, Asia and Australia and is on the Web at www.autonomy.com.
Note:
With the exception of historical information, the matters set forth in this news release are forward-looking statements that involve risks and uncertainties. A number of important factors could cause actual results to differ materially from those in the forward-looking statements. These factors include, among others, technology risks, including dependence on core technology; fluctuations in quarterly results; dependence on new product development; rapid technological and market change; reliance on sales by others; management of growth; dependence on key personnel; rapid expansion; growth of the Internet; financial risk management; and future growth subject to risks. These factors and other factors which could cause actual results to differ materially are also discussed in the company's filings with the United States Securities and Exchange Commission, including Autonomy's Registration Statements on Form F-1.
Summary: ...alerts on key initiatives and download reports that are of particular importance to them. The new portal has resulted in dramatic efficiency benefits: the AHA no longer has to manually build hundreds of thousands of links to sites; and members can now instantly access up-to-date information and make better,...
Summary: ...studies, frequently conducted in collaboration with the Department of Epidemiology and Biostatistics, the Department of Medicine and other departments, institutions and pharmaceutical companies, are used to guide clinical practice, drug research and development, and public health policies. The Prevention...
Summary: ...process by using Autonomy TeleForm to integrate document capture and workflow. Arizona State University (ASU) is increasingly seeking to recruit the best candidates to its graduate programs. As a result, the number of individuals applying to its 91 masters and 48 doctoral programs has grown from 13,829...
Summary: ...Japanese pharmaceutical giant chooses HP TRIM. Developing and introducing a new drug to the market is a lengthy and very expensive process. The development process adopted by pharmaceutical companies initially involves identifying an active compound, checking effectiveness and safety, and determining...
Summary: ...sick patients and potentially dangerous experimental drugs. Deviations from safety precautions and protocols approved by the Federal Drug Administration (FDA) may result in nonacceptance of the drug as well as life-threatening and unnecessary complications to participating patients. Prologue Research...
Summary: ...Sunstein Case Study. In simplified terms and as a testament to the success of the WorkSite deployment, Horn commented, “Nearly everything we need to serve clients is in WorkSite, properly maintained, and highly accessible to individuals with access rights. And while cost savings and efficiency are very...
Summary: ...with manufacturing plants on five continents. At their Burton upon Trent site in England, Johnson Controls manufactures automotive systems for the nearby Toyota assembly plant at Burnaston. The Challenge The company’s traditional purchase requisition process, which is vital to meeting its manufacturing...
Summary: ...Scotiabank Case Study. Liu added, “Everything is maintained in the system with an audit trail, which means no paper is used or required.” Liu commented on additional benefits, “Scrittura automates many steps of pre- and post-trade activity with instant document generation, integrated document management,...
Summary: ...port authority on the African continent in terms of the cargo volumes it handles. Securing mission-critical data, anytime, anywhere Prior to selecting Autonomy Connected Backup, TNPA’s users were required to manually save their valuable data, an inefficient and unreliable process that presents risk...
Summary: ...a Distributed Web Presence with Autonomy Like other educational enterprises, Education Management Corporation (EDMC) relies on the web as an increasingly vital channel for reaching prospective students. “For our business, topline growth depends on student acquisition, and we’ve found that leads generated...
This is a small selection of the Autonomy case studies available, please visit our publications site at http://publications.autonomy.com/ for more information.
Summary: ...Industry Regulatory Authority) Regulatory Notice 10-06, issued in January, 2010, requires member firms to supervise and archive content posted to social media sites. The Food and Drug Administration (FDA), Federal Trade Commission (FTC), and the National Futures Association (NFA) are also developing rules...
Summary: ...business purposes. The Food and Drug Administration (FDA), Federal Trade Commission (FTC), and the National Futures Association (NFA) are also developing rules associated with the use of social media. Reputational Risk Social media is now a vital way to communicate and engage with customers and prospects...
Summary: ...to stay ahead of the convergence of backup and recovery with operational processing in the cloud. Meaning Based Data protection allows enterprises to act on data based upon meaning and gain access to vital mobile data, fulfill regulatory compliance, archiving and litigation requirements – achieving...
Summary: ...to stay ahead of the convergence of backup and recovery with operational processing in the cloud. Meaning Based Data protection allows enterprises to act on data based upon meaning and gain access to vital mobile data, fulfill regulatory compliance, archiving and litigation requirements—achieving speed,...
Summary: ...functionality can be added to the system and controlled through the interface as the enterprise’s security needs dictate. In a climate where security considerations are increasingly vital, Autonomy Virage’s technology powers the world’s leading defense agencies, securing the world’s most vital...
Summary: ...dollars in derivatives every day, rely on Autonomy GCM solutions to: • Automate post-trade document and message operations • Expose and make discoverable vital documentation across the enterprise • Remain compliant with operational risk and reporting • Enable real-time STP connectivity to utilities...
Summary: ...Autonomy Cloud Solutions. info@us.autonomy.com Autonomy Systems Ltd, an HP Company Cambridge Business Park, Cowley Rd, Cambridge CB4 0WZ, UK Tel: +44 (0) 1223 448 000 Fax: +44 (0) 1223 448 001 Email: autonomy@autonomy.com Other Offices Autonomy has additional offices in Antwerp, Barcelona, Beijing, Boston,...
This is a small selection of the Autonomy Product Briefs available, please visit our publications site at http://publications.autonomy.com/ for more information.
Summary: ...through an economic crisis LEGAL TECHNOLOGY: Editor Richard Brent rbrent@ark-group.com Head of editorial Kate Clifton kclifton@ark-group.com Production editor Veronique Van Ham vvanham@ark-group.com Head of production Danielle Filardi dfilardi@ark-group.com Advertising sales John Kearns jkearns@ark-group.com...
Summary: ...an organization's data and forms a conceptual understanding of information in real-time, providing a platform for the automatic categorization, tagging, linking, retrieval and profiling of all forms of unstructured information regardless of repository, thereby enabling the automatic delivery of large...
Summary: ...itself, related information, or both. Its key benefits include: • Removing the need to manually insert XML tags • Allowing interoperability between applications that use different XML tagging rules • Allowing applications to use idea distancing (vital relationship between seemingly separately tagged...
Summary: ...Social Media and Information Compliance - Autonomy whitepaper. SEC 17a3-a4 or FSA COBS 11.8 2 See also, warning sent to Novartis regarding advertising links posted on corporate Facebook site. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/...
Summary: ...The Business Process Management Guide for Government. Cardiff serves more than 8,000 customers worldwide, including many in the financial services, pharmaceutical, healthcare, education, government and manufacturing industries. Cardiff is an Autonomy Group company (LSE: AU or AU.L). Appendix: Case Studies...
Summary: ...The Business Process Management Guide for Healthcare. Cardiff serves more than 8,000 customers worldwide, including many in the financial services, pharmaceutical, healthcare, education, government and manufacturing industries. Cardiff is an Autonomy Group company (LSE: AU or AU.L). Appendix: Case Studies...
Summary: ...component deliveries that in practice, are influenced by additional pieces of information that relate to changes in manufacturing techniques, support issues or installation instructions. Normally, at this point the automation of supply chain management breaks down, as human beings manually have to process...
Summary: ...Platform limitation for both authentication and viewing document results e.g. Windows IIS Complex configuration • Indexes can only be related to a single security type • Manually maintaining user-group, and user alias mappings • Doesn’t scale for single sign-on authentication The bottom line is...
Summary: ...Solution GARP® can also be used to “cut through debates about what should happen to records,” and is also useful in helping organizations “select systems that will meet the criteria laid out by GARP® to ensure effective and efficient management of vital business records in both local and global...
Summary: ...and manufacturing industries. Cardiff is an Autonomy Group company (LSE: AU or AU.L). Cardiff (USA) 3220 Executive Ridge Vista, CA 92081 Tel: 760.936.4500 Fax: 760.936.480 Email: information@cardiff.com Cardiff (UK) Cambridge Business Park, Cowley Rd, Cambridge CB4 0WZ, UK Tel: +44 (0) 1223 448 000 Fax:...
Summary: ...that is required for legal use. For instance, a pharmaceutical company in process of a lawsuit for a particular drug can search all archived web content that mentions the particular drug and replay the web content that visitors may have seen. Sophisticated compliance monitoring capabilities within the...
Summary: ...assistance, and customer surveys, to help contact centers manage and enhance customer service. Call recording and performance solutions are delivered on the same platform, providing the ability to link agent evaluations and customer surveys directly to a call recording. A centralized desktop interface...
This is a small selection of the Autonomy White Papers available, please visit our publications site at http://publications.autonomy.com/ for more information.
Related Case Studies
Find us on Facebook
Follow us on Twitter
See us on YouTube
Find us on LinkedIn
